Secukinumab demonstrates sustained efficacy in clearing skin and improving patient-reported outcomes in patients with moderate-to-severe psoriasis through 2 years of treatment: Results from the CLEAR study

Diamant Thaçi*, Lluís Puig, Kristian Reich, Tsen Fang Tsai, Stephen Tyring, Külli Kingo, Michael Ziv, Andreas Pinter, Ronald Vender, Aude Lacombe, Summer Xia, Vaishali Bhosekar, Isabelle Gilloteau, Adriana Guana, Andrew Blauvelt

*Corresponding author for this work
3 Citations (Scopus)
Original languageEnglish
JournalJournal of the American Academy of Dermatology
Issue number6
Pages (from-to)1405-1409
Number of pages5
Publication statusPublished - 12.2019

Research Areas and Centers

  • Academic Focus: Center for Infection and Inflammation Research (ZIEL)

Cite this